Catalio Capital Management, LP β Full Portfolio
106 tracked investments Β· listed companies and verified rows first
Clinical-stage biopharmaceutical company focused on identifying, developing and commercializing differentiated medicines for cancer patients.
BiotechMedical DevicesNewtown Square, US
Brent Rice(Chief Commercial Officer)Jason Zhang(Director)Cong Xu(Director)Zhengbin (Bing) Yao(Executive Officer, Director)Stuart Lutzker(Director)
AtaiBeckley develops rapid-acting mental health treatments and therapies for patients with difficult-to-treat mental health conditions.
BiotechDeep TechDigital HealthMedical DevicesMental Health
Srinivas Rao(Co-Founder and Chief Executive Officer)Christian Angermayer(Founder and Chairman of the Board)
Avalyn Pharma develops a nebulized inhalation treatment for pulmonary fibrosis designed to improve tolerability compared to existing oral therapies by directly delivering the drug to the lungs.
BiotechMedical Devices
Lyn Baranowski(CEO)in
Fractyl develops therapies for obesity and type 2 diabetes, focusing on non-drug-based approaches rooted in understanding metabolic disease mechanisms.
BiotechHealthtechMedical DevicesLexington, US
ALLAN WILL(Director)STANLEY LAPIDUS(Director)NIMESH SHAH(Director)CHRISTOPHER GABRIELI(Director)HARITH RAJAGOPALAN(Executive Officer, Director)JAY CAPLAN(Executive Officer, Director)
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon
Riley Ennis(Co-Founder and Chief Product Officer)Stuart Lawson(Director)Charles Roberts(Director)Gabriel Otte(Director)
Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.
BiotechDeep TechDigital HealthMedical DevicesWatertown, US
Matthew Fust(Director)Kari Stefansson(Director)Joshua Pinto(Executive Officer)Maykin Ho(Director)Alaa Halawa(Director)Tamara Tompkins(Executive Officer)
Helicons develops a peptide-based therapeutic platform designed to target intracellular proteins previously considered undruggable by combining the specificity of antibodies with the cell-penetrating properties of small molecules.
AI & Machine LearningBiotechDeep TechMedical Devices
Mathai Mammen(CEO, President and Chairman)
Abridge builds AI software that converts clinical conversations into structured insights for healthcare providers.
AI & Machine LearningDigital HealthHealthtechPhiladelphia, US
Shiv Rao(Founder & CEO)Julia Chapin(Executive Officer)Sagar Sanghvi(Executive Officer)
BoardAndy Weissman(Director)Sebastian Duesterhoeft(Director)Will Reed(Director)
AdvanCell develops radioisotope-based therapies, using Th-228 sourced through the U.S.
BiotechHealthtechMedical DevicesCambridge, US
Philina Lee(Executive Officer, Director)Aaron Pickett(Executive Officer)Wing Cheong Lam(Director)Nik Economopoulos(Director)Anthony Aiudi(Director)Jamil Beg(Director)
Amalgam develops a modular, AI-powered software-as-a-medical-device (SaMD) platform and EHR-integrated solutions for healthcare providers, health plans, and life sciences companies.
AI & Machine LearningDigital HealthHealthtechMedical DevicesWilmington, US
RYAN A. SYSKO(Executive Officer, Director)
BoardSONNY VU(Director)JEFFREY P. COURTNEY(Director)
BiotechRedwood City, US
Jeffrey Cleland(Manager of Company)Kannan Rangaramanujam(Manager of Company)Sujatha Kannan(Manager of Company)
BoardJustin Hanes(Manager of Company)
ATAI is developing rapid-acting, durable mental health treatments to address unmet needs in psychiatric conditions affecting over one billion people globally.
BiotechHealthtechMental Health
New York-based D2C provider of high-quality hearing aids in the US.
HealthtechNew York, US
Patrick Freuler(Executive Officer, Director)Andre Sequin(Executive Officer)
BiotechCambridge, US
Mohamed Genead(Executive Officer, Director)Michael Tolentino(Executive Officer, Director)David Callanan(Executive Officer)Tarek Hassan(Executive Officer)Derek Kunimoto(Executive Officer)
BoardDavid Guyer(Director)
HealthtechAuburndale, US
Samantha Pulliam(Executive Officer, Director)Vincent Ricci(Executive Officer)Jim O'Connor(Executive Officer)Shacey Petrovic(Executive Officer, Director)Eileen Maus(Executive Officer, Director)
BoardJonathan Dean(Director)
Bayesian Health develops clinical artificial intelligence for real-time patient monitoring and clinical decision support.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Dr. Suchi Saria
Boston, US
Jacob A. Donoghue, M.D., Ph.D.(Executive Officer, Director)Jarrett Revels(Executive Officer)Jacob A. Donoghue(Executive Officer, Director, Promoter)
BoardCaitlin Donovan(Director)Pavel Raifeld(Director)Naveen Rao(Director)
Blackrock Neurotech develops a neurotechnology platform, including brain-computer interface systems, aimed at improving patient lives and treating neurological conditions.
BiotechDeep TechMedical Devices
Florian Solzbacher(Co-Founder & CSO)Marcus Gerhardt(Co-Founder & CEO)Thomas Thiele(CFO)Christian Angermayer(Co-Chairman)Tim Sievers(Co-Chairman)
Cambrian Bio is a clinical-stage biopharmaceutical company developing precision therapeutics targeting metabolic pathways associated with aging, including AMPK and mTOR.
BiotechLongevityMedical DevicesNew York, US
James G. Peyer(Executive Officer, Director)Juliette Han(Executive Officer, Director)Mark Nuttall(Executive Officer)Ruth Thieroff-Ekerdt(Executive Officer)William DeVaul(Executive Officer)Christian Angermeyer(Director)
Combines single-cell RNA analysis technology from the Broad Institute with AI/ML models and large-scale clinical sample collection for novel drug discovery and precision medicine.
HealthtechCambridge, US
Michael Boretti(Executive Officer)Tariq Kassum(Executive Officer, Director)Christoph Lengauer(Executive Officer, Director)
Centenara Labs is a longevity-focused drug discovery company that translates research on the biology of aging into therapies intended to improve healthy aging and extend lifespan.
BiotechHealthtechLongevity
Christian Angermayer(Founder)
Centrexion is a pharmaceutical company developing drugs in two therapeutic areas: non-opioid pain relief and immunology.
BiotechBaltimore, US
Sol Barer(Director)Kerrie L. Brady(Executive Officer)James N. Campbell(Executive Officer, Director)Shengda Zan(Director)Gregg Beloff(Executive Officer)Arnold L. Oronsky(Director)
BiotechJersey City, US
Cheng Zhang(Executive Officer, Director)
BoardVivek Garipalli(Director)Nick Olsen(Director)Peter DiLaura(Director)
Cresilon is a Brooklyn-based medical device company that develops plant-based hydrogel hemostatic products to rapidly stop bleeding.
BiotechHealthtechMedical DevicesBrooklyn, US
Isaac Miller(Co-founder)Joseph Landolina(Executive Officer, Director)Scott Levine(Executive Officer)Joe Landolina(Co-founder)
BiotechBrookline, US
Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)
BoardGeorge M. Church(Director)
Boston, US
Georgiamune develops targeted immunomodulator drugs designed to regulate immune signaling pathways for treating cancer and autoimmune diseases.
BiotechHealthtech
Hippocratic AI develops generative AI agents designed for healthcare delivery, working with hospital systems, health plans, and life sciences companies to support clinical decision-making and patient care.
AI & Machine LearningDigital HealthHealthtech
Munjal Shah(Chief Executive Officer, Co-founder)inDr. Meenesh Bhimani(Chief Medical Officer, co-founder)inVishal Parikh(Chief Product Officer, Co-founder)inSubho Mukherjee(Chief Science Officer, Co-founder)in
Leo Cancer Care develops upright radiotherapy systems, including patient positioning, imaging, and treatment solutions for photon and particle (proton) therapy.
HardwareHealthtechMedical Devices
LifeSprout develops tissue-engineering products for aesthetic and regenerative medicine, designed to restore soft tissue losses caused by aging, cancer, and metabolic disease.
BiotechHealthtechMedical DevicesBaltimore, US
Hai-Quan Mao(Executive Officer, Promoter)Sashank Reddy(Executive Officer, Director, Promoter)Gregory Sieczkiewicz(Executive Officer, Director, Promoter)
LILA Sciences builds AI systems for autonomous scientific research and discovery across medicine, materials, energy, and defense sectors.
AI & Machine LearningBiotechDeep TechSaaS
NextPoint is developing precision cancer therapeutics based on the B7-H7/HHLA2 axis, including T-cell engagers, antibody-drug conjugates, and checkpoint inhibitors for cancer patients.
BiotechDigital HealthMedical DevicesAustin, US
Ivan Cheung(Executive Officer, Director)Axel Hoos(Director)Jeffrey Lacey(Executive Officer)
BoardDetlev Biniszkiewicz(Director)R. Jacob Vogelstein(Director)Brian Shuster(Director)
Octant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases.
AI & Machine LearningBiotechDeep TechMedical DevicesEmeryville, US
Sri Kosuri(Co-founder)in
Creating next generation precision medicines for patients with cancer and inflammatory diseases by targeting key signaling nodes.
BiotechCambridge, US
Valerie Odegard(Director)Jeffrey Leiden(Director)Charles Baum(Director)Gary D Glick(Executive Officer, Director)
BoardJill Carroll(Director)Carl Gordon(Director)
OnCusp Therapeutics develops oncology therapeutics for cancer treatment, including antibody-drug conjugates and small molecule compounds in clinical and preclinical stages.
BiotechMedical DevicesNew York, US
Dr. Bing Yuan(Co-Founder, Chief Executive Officer)Dr. Eric Slosberg(Co-Founder, Chief Development Officer)Dr. Andy Fu(Co-Founder, Chief Business Officer)
AI company developing a medical search engine used by physicians for clinical decision support.
HealthtechNew York, US
Jeffrey Lightcap(Director)David Klimstra(Executive Officer)Peter Hamilton(Executive Officer)Antoine Munfa(Director)William Andrew Moye(Executive Officer, Director)Asish Xavier(Director)
BiotechSouth San Francisco, US
Watson Debi(Director)Anne Rubin(Executive Officer, Director)Kirsten Angela Macfarlane(Executive Officer, Director, Promoter)Cameron Wheeler(Director)Randall Olson(Director)Robert Jackson(Director)
San Francisco, US
BoardChristy Shaffer(Director)Chau Khuong(Director)Sevgi Gurkan(Executive Officer, Director, Promoter)
Pheast Therapeutics develops immunotherapies targeting cancer, building on foundational research from Stanford's stem cell research institute.
BiotechHealthtechMedical DevicesRedwood City, US
Irv Weissman(Cofounder, Scientific Advisor, Board Director)Ravi Majeti(Cofounder, Scientific Advisor, Board Observer)Amira Barkal(Principal Founder, Scientific Advisor, Board Director)Roy Maute(Cofounder & Chief Executive Officer)
BoardJacob Vogelstein(Director)Steven Gillis(Director)
Natick, US
Shawn Liu(Director)Hui Yang(Director)Gang Song(Executive Officer, Director)Zhaohui Wang(Director)Robert Forrester(Director)Hong Fang Song(Director)
HealthtechPleasanton, US
Sung Kim(Executive Officer)Jason Orchard(Director)Leonard Liptak(Executive Officer, Director)Steven Pacelli(Director)Heather Rider(Director)Laing Rikkers(Executive Officer, Director)
RefleXion Medical develops SCINTIX autonomous radiotherapy, an external beam theranostic oncology platform that uses biological signals from radiopharmaceutical-labeled cancer cells to deliver real-time, motion-managed radiation to lung and bone tumors from primary or metastatic disease.
BiotechHealthtechMedical DevicesHayward, US
Resilience is a contract development and manufacturing organization (CDMO) that manufactures complex pharmaceutical products and active pharmaceutical ingredients to broaden access to medicines and protect biopharmaceutical supply chains against disruption.
Advanced ManufacturingBiotechEnterprise SoftwareBlue Ash, US
William S. Marth(Chief Executive Officer)
BoardRobert Nelsen
Septerna develops oral small molecule drug candidates targeting G protein-coupled receptors (GPCRs) using its proprietary Native Complex Platform.
BiotechDeep TechSouth San Francisco, US
SetPoint Medical develops an implantable wireless device that stimulates the vagus nerve to reduce inflammation and treat rheumatoid arthritis through a neuroimmune modulation approach.
BiotechHealthtechMedical DevicesValencia, US
HealthtechCambridge, US
Rahul Dhanda(Executive Officer, Director)James Collins(Director)David Walt(Director)
BoardIssi Rozen(Director)
Singular Genomics develops spatial pathology technology to map molecules and cells directly in tissue for disease characterization.
BiotechDeep TechMedical Devices
John Stark(CEO)Aaron Berlin(CTO)
HealthtechBaltimore, US
Carolyn Reed Yarina(Executive Officer, Director)Katherine Kirsch(Executive Officer, Director)Gillian Henker(Executive Officer, Director)
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.